<DOC>
	<DOCNO>NCT02356328</DOCNO>
	<brief_summary>This observational study intend collect outcome data cohort 30 patient suffer dry eye disease due chronic ocular Graft-versus-Host Disease ( GvHD ) treat medical device NovaTears® eye drop duration 11 13 week .</brief_summary>
	<brief_title>NovaTears® Eye Drops Observational Study NT-003</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>According NovaTears® instruction use ≥ 18 year Patients allogeneic hematopoietic stem cell transplantation dry eye disease due chronic ocular GraftversusHost Disease Ability willingness provide write Informed Consent Ability willingness participate examination Willingness ability return follow visit Patients know hypersensitivity component NovaTears® Patients contact lenses , pregnancy , breast feeding Patients dry eye disease cause know underlying systemic disease Patients plan ophthalmologic surgical procedure course PMCF study Patients use lipidcontaining tearfilm stabilize eye drops/sprays except cyclosporin formulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>